PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development
Las Vegas, Nevada--(Newsfile Corp. - April 14, 2021) - CECORS, INC. (OTC Pink: CEOS) ("CeCors" or the "Company") is pleased to announce that its wholly owned Canadian subsidiary PsyKey Inc. has entered into a letter of intent with MycoVita Canada Inc. ("MycoVita") to form a strategic partnership. The PsyKey - MycoVita strategic partnership will focus on the research, development, and commercialization of Mycology-based formulations, products, and therapeutics, including exploring scientific...
2021-04-14 12:15 PM EDT
PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board
Las Vegas, Nevada--(Newsfile Corp. - March 29, 2021) - CECORS, INC. (OTC Pink: CEOS) ("CeCors" or the "Company"), through its wholly owned subsidiary PsyKey Inc., a vertically integrated company engaged in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients, formulations and technologies, is pleased to announce the appointment of capital markets and financial risk specialist David Gibbins as head of its Strategic Advisory Board. In his...
2021-03-29 9:35 AM EDT
Cecors, Inc. Shareholder Update
Las Vegas, Nevada--(Newsfile Corp. - January 14, 2021) - CECORS, INC. (OTC PINK: CEOS) ("CeCors" or the "Company"), is pleased to announce that the Company is transitioning into the Psychedelics Market, with a direction that includes a complete overhaul of the management team, bringing the Company to current status and delivering exciting growth for our shareholders.To view an enhanced version of this
2021-01-14 9:45 AM EST